Alginate Market Total Revenue Will Beat $923.8 Million By 2025 | CAGR: 4.5%: Grand View Research, Inc.

According to a report published by Grand View Research, Inc.; the global alginate market is anticipated to reach a valuation of around USD 923.8 million by 2025. Growing demand from food, pharmaceutical, industrial, and other applications can propel the market over the forecast period (2014 to 2025).

High demand for alginate as a thickening and gelling agent in food and beverage and bakery and confectionery is expected to boost the market growth in the forthcoming years. Rising demand for ice creams, beer, and yogurt is likely to drive the demand from food and beverage sector. Increasing use as an emulsifier in salad dressings, margarine, frozen desserts can also spur the alginate market growth during the forecast period. Extensive usage in pharmaceuticals as a thickening agent, emulsion stabilizer, disintegrated, and film-forming agent for tablets can also bode well for market expansion. Rising use of alginate in tablet coatings due to its superior characteristics is likely to bolster the market growth during the forecast period.

Browse In-depth Insights: www.grandviewresearch.com/industry-analysis/alginate-market

The worldwide alginate market can be segmented on the basis of type, product, application, and regions. As per type, the market can be classified into High M and High G. The high M segment is expected to grow at a CAGR of around 4.2% from 2016 to 2025. Based on product, the market can be categorized into sodium, calcium, potassium, propylene glycol, and others. On the basis of application, the market can be split into food, pharmaceutical, industrial, and others. Geographically, the market can be divided into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa.

In 2016, North America held around 26.2% of the overall market share in terms of demand owing to high utilization in established food and beverage and pharmaceutical sectors. Growing pharmaceutical industry in the U.S. due to high healthcare spending is expected to have a positive impact on the global market for alginate.

The Central & South America market is anticipated to hold considerable market share over the forecast period on account of increasing use of the product in paper industry. In addition, high demand from food and beverage industry for the production of ice creams, lactic acid drinks, and jellies is anticipated to further drive the alginate market during the forecast period.

Asia Pacific is likely to grow at a CAGR of around 5.9% in the forthcoming years owing to rapidly growing textile and food and beverage industries. Presently, adoption of alginate in the pharmaceutical sector is relatively inadequate due to limited demand from the emerging economies. However, the demand is anticipated to propel over the forecast period, creating expansion opportunities for the market players.

Europe is expected to showcase significant growth over the projected period due to the presence of major manufacturers and their involvement in the development of advanced products. High availability of raw materials in Norway and Chile supports the production. The product price in the region is expected to remain high owing to increasing demand for high-purity and quality.

The Middle East region is expected to witness high demand for alginate over the forecast period due to growing applications in food and beverage industry. High demand for convenience foods due to rising attraction for exotic food products from around the world. This trends is likely to promote the market development during the forecast period.

Prominent players operating in the alginate market include Ingredients Solutions, Inc.; SNAP Natural & Alginate Product Pvt. Ltd.; SNP, Inc.; IRO Alginate Industry Co., Ltd.; and Dohler Group. Major participants in the market are focusing on research and development (R&D) activities to develop advanced products. Market players are making more efforts to develop advanced product grades to attract more customers. Most companies are employing sustainable manufacturing techniques to tackle issues like the effect of unsustainable seaweed harvesting.

The companies operating in the Chinese alginate market are supplying the product across the world to bridge the huge supply-demand gap in domestic production. Increasing investments from governments and private companies for the development of seaweed processing are likely to support the market growth.

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-alginate-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Prefilled Syringes Market Total Revenue Would Surpass $22.5 Billion by 2025 | CAGR 11.2%

The global Prefilled Syringes Market size is expected to reach a value of USD 22.5 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.2% during the forecast years. Growing usage of prefilled syringes and technological advancements in auto-injectors are the key factors driving the market. Prefilled syringes are rapidly replacing traditional syringe-vial combinations due to advantages offered by them, such as increased patient safety and convenience for healthcare practitioners in dose preparation and delivery.

These syringes enable easy management of chronic diseases, such as diabetes and rheumatoid arthritis, which is expected to boost the usage of autoinjectors and pen injectors during the forecast period. Thus, growing prevalence of diabetes and other chronic diseases would fuel the market demand over the next few years. The introduction of advanced devices with Wi-Fi and Bluetooth connectivity facilitating effective management of patient health records is also expected to boost the product demand.

Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and other biotech drugs, which otherwise tend to become unstable and react with the material of the container resulting in altered drug potency. Rising preference for biotechnology drugs and emerging biotech sector presenting greater opportunities are expected to have a positive impact on the market development during the forecast period.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market

Further key findings from the study suggest:

• Currently, the use of glass prefilled syringes is greater than plastic syringes owing to high demand from healthcare professionals. Glass prefilled syringes are easy to use and lower the risks at the time of injection
• However, the plastic syringes are rapidly replacing glass syringes due to the advent of advanced, biocompatible materials, such as Polypropylene (PP) and crystal clear polymer
• Europe was the dominant regional market for prefilled syringes in 2015. High adoption of patient safety measures and presence of key companies are the factors responsible for its the region’s growth
• On the other hand, North America is expected to witness the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region
• Major companies in the global market are Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation, Owen Mumford Ltd., Schott Group, Datwyler Pharma Packaging, and Becton, Dickinson and Company
• The market for prefilled syringe manufacturing is consolidated; however, new companies are bringing innovative technologies to this field, which can be used for the manufacturing of auto-injectors.

Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and region:

Prefilled Syringes Type Outlook (Revenue, USD Million, 2014 - 2025)

• Disposable
• Reusable

Prefilled Syringes Material Outlook (Revenue, USD Million, 2014 - 2025)

• Glass
• Plastic

Prefilled Syringes Application Outlook (Revenue, USD Million, 2014 - 2025)

• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Others
  • Vaccines and Other Biotech Drugs

Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers

Prefilled Syringes Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-prefilled-syringes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transplant Diagnostics Market Is Predicted To Beat $895.2 Million By 2024: Grand View Research, Inc.

The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

• PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing
• The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth
• In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase
• North America captured the largest revenue share in 2016 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
• Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, medical tourism industry, and awareness regarding organ donation
• Some major players in this market are Thermo Fisher Scientific, Inc.; Illumina, Inc.; F.Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.

Grand View Research has segmented the global transplant diagnostics market on the basis of technology, product, and region:

Transplant Diagnostics Technology Type Outlook (Revenue, USD Million, 2014 - 2024)

• Molecular Assay
  • PCR-based Molecular Assay
  • Sequencing-based Molecular Assay
• Non-molecular Assay
  • Serological Assay
  • Mixed Lymphocyte Culture Assay

Transplant Diagnostics Product Type Outlook (Revenue, USD Million, 2014 - 2024)

• Reagents & Consumables
• Instruments
• Software and Services

Transplant Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-transplant-diagnostic-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Tissue Expanders Market Is Poised To Reach Around $1.5 Billion By 2025 | CAGR: 5.5%: Grand View Research, Inc.

According to the findings of a research report published by Grand View Research, Inc.; the tissue expanders market is projected to reach a valuation of USD 1.5 billion by 2025. The market is anticipated to expand at a healthy growth rate of 5.5 % during the forecast period (from 2018 to 2025). Growing incidences of trauma cases and severe road accidents are considered as major driving factors for the tissue expanders. Severe scars or deformities caused due to accidents require surgical treatment or cosmetic surgeries in most of the cases. This is projected to propel the market demand in the coming years.

Moreover, growing cases of breast cancer has also increased the demand for mastectomy and lumpectomy procedures, which, in turn, will boost the market growth in the next few years. The global tissue expanders market is segmented into application, shape, end-use, and region. On the basis of application, the market is bifurcated into breast reconstruction, forehead skin and scalp reconstruction, face and neck reconstruction, and others. In 2016, forehead skin and scalp reconstruction segment estimated notable revenue. This is due to increasing demand for these procedures as a result of growing number of trauma and burn cases.

Browse In-depth Insights: www.grandviewresearch.com/industry-analysis/tissue-expander-market

On the basis of shape, the market is classified into anatomical, round, rectangular, crescent, and others. In 2016, anatomical-shaped tissue expanders accounted the largest market share. This growth is attributed to the rising demand for these expanders as they offer more natural-looking appearance. On the basis of end-use, the market is split into hospitals, cosmetology clinics, and ambulatory surgical centers. On the basis of geographies, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).

In 2016, North America tissue expanders market acquired the largest industry share due to well-established healthcare infrastructure and increasing healthcare expenditure. In 2014, as per the American Society of Plastic Surgeons, US had the highest number of breast reconstructive surgeries. Canada has a considerable contribution toward the region’s growth owing to high prevalence of breast cancer. After skin cancer, breast cancer is considered as the most common type of cancer among women in America, according to the Breast Cancer Research Foundation (BCRF). The BCRF also estimated that around 231,840 new cases of invasive breast cancer were detected.

In 2016, Europe contributed a noteworthy share on account of the rise in cases of road accidents in Germany. The region is estimated to expand further during the forecast years on account of the increasing number of cosmetics surgeries in UK. The Asia Pacific regional market for tissue expanders is likely to witness the fastest growth during the forecast period. This growth is credited to the rising number of road accidents and trauma cases in India. Additionally, with around 10,000 plastic surgery clinics, China is one of the major cosmetic industries in the world. This is also expected to boost the market growth in the Asia Pacific region.

Some of the prominent companies operating in the global tissue expanders market include Sientra, Inc.; Mentor Worldwide LLC; KOKEN CO.; Guangzhou Wanhe Plastic Materials Co. Ltd; and Guangzhou Wanhe Plastic Materials Co. Ltd. Most of these market participants focus on the development of new products and strategic alliance to expand their regional expansion.

For instance, a leading medical aesthetics company called Sientra, Inc. recently announced the launch of a charitable program, Full Circle, for supporting the research activities on breast cancer detection, prevention, and treatment. The program will also help raise awareness among the breast cancer and breast reconstruction group. As part of this program, the company donated a share of each tissue expander sale to various breast cancer awareness and support activities. The company has also developed expanders such as AlloX2 and Dermaspan. The AlloX2 features drain technology, which enables plastic surgeons to non-surgically address the accumulation of serous fluid that can result in common postoperative complications like seroma.

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-tissue-expander-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Restorative Dentistry Market Is Estimated To Generate $25.9 Billion By 2025: Grand View Research, Inc.

According to a report published by Grand View Research, Inc.; the reconstructive dentistry market is anticipated to reach a valuation of USD 25.9 billion by 2025. The market is also expected to grow at a CAGR of 6.7 % during the forecast period (from 2018 to 2025). Factors such as increasing number of dental practices, development of digital dentistry, and growing dental tourism can propel the market growth during the forecast period. In addition, rising demand for cosmetic dentistry and implants due to increased focus on aesthetics is also expected to drive the market development in coming years.

Furthermore, dental practices are shifting from individual practices to multi-unit, group, and corporate dental practices. These practices are performed with an aim to provide efficient and high-quality care to patients. This is also likely to fuel the market growth over the next few years. Technological advancements in digital dentistry such as digital radiography, CAD/CAM systems, caries diagnosis, computer-aided implant dentistry, and intraoral imaging is also expected to boost the market growth.

Browse In-depth Insights: www.grandviewresearch.com/industry-analysis/restorative-dentistry-market

Worldwide restorative dentistry market is segmented on the basis of product type, end-use, and region. On the basis of product type, the market is categorized into restorative materials, implants, prosthetics, and restorative equipment. In 2016, restorative materials segment estimated for the largest market share and is expected to show high growth even during the forecast period. This growth is attributed to the increasing use of these materials to fabricate tooth restorations. The dental implants segment is also likely to have a significant development owing to high demand for enduring aesthetic restoration and increasing awareness about its advantages.

On the basis of end-use, the market is classified into research and teaching institutes, dental hospitals and clinics, and dental labs. Dental hospitals and clinics segment estimated for the largest market share in the past and is projected to continue its dominance over the forecast period due to increasing number of dental clinics/hospitals. On the basis of geographies, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).

The Europe region led the global market in 2016 on account of high number of oral disease cases. The region is projected to expand further during the forecast years due to the quick adoption of newer, advanced technologies and products and increasing number of dental practices & hospitals. In addition, strong presence of major companies in Europe is also contributing toward the development of the market in this region.

The Asia Pacific regional market is expected to grow at the highest CAGR during the estimated period. This growth can be associated with the growing population and increasing number of dental practices. In addition, rising awareness among people about oral health along with increasing geriatric population base would also fuel the demand for restorative dentistry, thereby augmenting region’s growth.

Furthermore, increasing number of dental colleges and hospitals is also likely to support the market growth in this region during the forecast period. For instance, according to an NCBI article titled, ‘The current status of dental graduates in India’ about 310 dental colleges noted in India in 2016. Additionally, growing dental tourism, particularly in developing countries such as India and China, is also expected to boost the region’s development in the coming years.

The introduction of restorative equipment, as well as new restorative materials, in the market would have a positive impact on the market demand. Some of the key players operating in the global restorative dentistry market include Ivoclar Vivadent AG; Mitsui Chemicals, Inc.; Dentsply Sirona; Zimmer Biomet; and Mitsui Chemicals. Most of these market participants are mainly focusing on launching innovative products to get an edge over each other.

For instance, Prisyna, the oral care division of Synedgen, recently received clearances from the U.S. Food and Drug Administration (FDA) for its Moisyn products designed for treating xerostomia. Xerostomia is also known as dry mouth syndrome, which occurs in case of decrease of saliva and impacts the patient’s quality of life to a great extent. It leads to sleep disturbance, painful oral tissues, bad breath, and trouble in chewing, speaking, and swallowing.

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-restorative-dentistry-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Plant Phenotyping Equipment Market Is Anticipated To Boosting Approx. $276.86 Million By 2025

The global Plant Phenotyping Equipment Market size is estimated to reach USD 276.86 million by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.51% over the forecast period. Global population is projected to surpass 9 billion by 2050, thus posing the challenge of adequate crop production to meet rising food needs. This, in turn, is expected to open up potential opportunities for crop improvement and plant science. However, adequate crop production would be challenging, particularly since crop production has been rising by approximately 1.3% per year on an average. This is not sufficient to meet the pace of population growth. Plant phenotyping is emerging as an effective means to overcome this challenge. Thus, the plant phenotyping equipment market is expected to witness significant growth over the forecast period.

Plants have different optical properties; healthy plants transmit, emit, reflect, absorb, and fluoresce with electromagnetic radiation in a different manner as compared to infected plants. Imaging techniques assist in detecting these properties, particularly those invisible to naked eye. Imaging methodologies, such as imaging spectroscopy, infrared imaging, fluorescence imaging, and visible light imaging among others, are increasingly being used to aggregate multi-level phenotype data. This data ranges from macroscopic to molecular scale for a duration of a few seconds to a few weeks.

Spectroscopy imaging helps measure interaction of solar radiation with plants and is one of the promising methodologies used for plant phenotyping. This methodology is suitable for field phenotyping when used with aerial platforms. However, cost of spectral cameras is comparatively higher. Infrared imaging technologies aid in screening objects of internal molecular movements which release infrared radiation and offer precise measurement and spatial resolution under altering environmental conditions.

Fluorescence imaging is used in many areas of plant physiology. It provides diagnostic tools to resolve heterogeneity issue of leaf photosynthetic performance. Its applications are limited to a single leaf or seedling levels of a model crop. Visible light imaging is easy to use and cost-effective. This imaging system offers 2D images using a wavelength perception similar to the human eye. The images can be used to monitor changes in a plant’s biomass and to study numerous phenotypic characteristics.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/plant-phenotyping-equipment-market

Further key findings from the report suggest:

• Rapidly increasing population across the world has boosted demand for agricultural goods
• Advancements in imaging techniques are facilitating a better assessment of plant characteristics, thereby helping in development of better plant breeds
• North America plant phenotyping equipment market is expected to witness significant growth owing to increasing research activities
• Key market participants include Keygene; Heinz Walz GmbH; LemnaTec GmbH; Photon Systems Instruments; spol. s.r.o.; and Qubit Systems Inc.

Grand View Research has segmented the global plant phenotyping equipment market on the basis of equipment, end use, application, and region:

Plant Phenotyping Equipment Outlook (Revenue, USD Million, 2013 - 2025)

• Hardware
  • Sensor modules
    • Ultrasonic Distance Sensors
    • NDVI Sensors
    • RGB Web Cameras
    • Portable Spectrometers
    • Temperature Sensors
    • Humidity Sensors
  • Imaging devices
    • Infrared Imaging
    • Fluorescence Imaging
    • Structural Tomography
    • Position Emission Tomography (PET)
    • Hyperspectral imaging
    • Others (Magnetic Resonance Imaging, Forster Resonance Energy Transfer, NIR Imaging)
  • Automated System
    • Bench-based
    • Conveyor based
  • Drones
  • LED Lightings
  • Portable Devices
• Software

Plant Phenotyping Equipment End Use Outlook (Revenue, USD Million, 2013 - 2025)

• Greenhouse
• Field
• Laboratory

Plant Phenotyping Equipment Application Outlook (Revenue, USD Million, 2013 - 2025)

• Plant Research
• Breeding
• Product Development
• Quality Assessment

Plant Phenotyping Equipment Regional Outlook (Revenue, USD Million, 2013 - 2025)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Middle East & Africa
• South America
  • Brazil

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-plant-phenotyping-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Erythropoietin Drugs Market Size Would Be Around Of $17.4 Billion By 2025: Grand View Research, Inc.

The global Erythropoietin Drugs Market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

• The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
• The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
• Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
• Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
• Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
• The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
• Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

Grand View Research has segmented the erythropoietin (EPO) drugs market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 - 2025)

• Biologics
• Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cancer
• Hematology
• Renal Diseases
• Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com